Close

News

26/03/2014
New companies in the UAB Research Park
During the past year, eight new companies have moved into Eureka, the UAB Research Park iconic building next door to the Barcelona Synchrotron Park. These companies are: Infantium, Micro4ener, Delectatech, Health & SportLab, RiscControl, Acceplan, Mass Factory and Rizoma Lab.
 
All these companies are technology-based, some of them are partially owned by the UAB University itself, and they have been created by researchers from the campus or by entrepreneurs.
 
In order to promote the creation and the growth of companies like these ones, the UAB Research Park offers entrepreneurs incubation facilities, different advisory services on legal and fiscal issues, on promotion and marketing, etc.

These services are part of the general mission of the UAB Research Park to facilitate and promote the transfer of knowledge generated by the research groups of the campus as well as its R&D capacities for addressing the innovation needs of its social and economic environment like the companies set up in the Barcelona Synchrotron Park.

UAB Research Park
18/03/2014
The public-private partnership ESTEVE-UAB is bearing fruit
ESTEVE has announced the signing of two agreements that will enable it to progress the development of its gene therapeutic for the treatment of Sanfilippo A Syndrome and begin a phase I/II clinical trial in 2015. The agreements are with the North American biotechnology company REGENX Biosciences, LLC (REGENX) and with the French non for profit organization GÉNÉTHON.
 
Sanfilippo A is a rare and devastating neurodegenerative disease that affects approximately 1 in every 100.000 children that rarely survive past adolescence.

This gene therapy program is being developed in a public-private partnership between ESTEVE and the research team of Dr. Fàtima Bosch at the Center for Biotechnology and Gene Therapy of the Universitat Autònoma de Barcelona (UAB).

In this partnership, ESTEVE leads all activities associated with the management and protection of intellectual property, regulatory activities, the coordination and supervision of GMP manufacturing, the preclinical toxicology studies as well as all clinical development.
The CBATEG research team at the UAB brings to the partnership their scientific know-how and expertise in gene therapy including viral vector design and the development of preclinical disease models.

Press release
11/03/2014
Barcelona ranked fourth place among the most attractive European cities for investors
According to the new European Cities and Regions of the Future 2014/15 report published last month by fDi Magazine, a specialist division from The FT Ltd., Barcelona ranked seventh among the most attractive cities for investors rising 15 places from the previous ranking in 2012/13. The top three cities are London, Helsinki and Copenhagen.

Among large cities (more than 750,000 inhabitants), Barcelona ranked fourth behind London, Helsinki and Dublin, respectively.

Within this category, it may be mentioned that Barcelona provides the fifth best infrastructures behind Paris, London, Berlin and Copenhagen.
 
European Cities and Regions of the Future 2014/15
24/02/2014
Zero2infinity offers sightseeing flights in the stratosphere
The Zero2infinity Company located in the Parc Tecnològic del Vallès adjacent to the Barcelona Synchrotron Park, works to offer sightseeing flights in the stratosphere. The so-called Bloon project has already registered its first customers.

The Zero2infinity engineers work on a six-people capsule (four passengers and two pilots) pulled by a helium balloon to reach an altitude of 36 km in one hour. Once stabilized at that height, passengers will have two hours to enjoy the view over the black sky and the Earth’s curvature.
The first test with crew members is scheduled by the end of 2014 and the first commercial flights are expected by the end of 2015. Some people have already booked a seat paying €10,000, approximately 10% of the total cost of the ticket.

Bloon project web site: http://www.inbloon.com/
18/02/2014
Students from Harvard visited the Barcelona Synchrotron Park and ALBA
A group of students in urban planning from the American university of Harvard visited the Barcelona Synchrotron Park (BSP) and the ALBA synchrotron on February 18.

On a one-week working visit in Barcelona accompanied by their professor, the architect Joan Busquets, the group had the opportunity to learn about the BSP strategy to become a magnet for innovative companies in the framework of science and technology parks policy and to visit the synchrotron facilities.
11/02/2014
Applications of the Alba synchrotron in the materials and chemistry industries
Tuesday, April 15:
Meeting at the Alba synchrotron to make synchrotron radiation applications known to materials and chemistry industries.

The Alba operative beam lines related to direct applications in the materials and chemistry sectors including the challenges of the Horizon 2020 European R&D program will be presented. Powder diffraction, non crystalline diffraction, emission, absorption and photo emission spectroscopies techniques will be addressed.
This meeting is exclusively aimed at users that make a commercial (private) use of the synchrotron radiation.

Free meeting.
More information and mandatory registration:
http://indico.cells.es/indico/conferenceDisplay.py?confId=7
42 43 44 45 46 47 48 49